Literature DB >> 1454521

Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53.

D M Milne1, R H Palmer, D W Meek.   

Abstract

The p53 tumour suppressor protein is phosphorylated by several protein kinases, including casein kinase II. In order to understand the functional significance of phosphorylation by casein kinase II, we have introduced mutations at serine 386 in mouse p53, the residue phosphorylated by this kinase, and investigated their effects on the ability of p53 to arrest cell growth. Replacement of serine 386 by alanine led to loss of growth suppressor activity, while aspartic acid at this position partially retained suppressor function. These data suggest that the anti-proliferative activity of p53 is activated by phosphorylation at serine 386, and establish a direct link between the covalent modification of a growth suppressor protein and regulation of its activity in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454521      PMCID: PMC334387          DOI: 10.1093/nar/20.21.5565

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  49 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme.

Authors:  D M Milne; R H Palmer; D G Campbell; D W Meek
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

3.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

4.  The MCK enhancer contains a p53 responsive element.

Authors:  H Weintraub; S Hauschka; S J Tapscott
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

Authors:  P Shaw; R Bovey; S Tardy; R Sahli; B Sordat; J Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

7.  Wild type human p53 is antiproliferative in SV40-transformed hamster cells.

Authors:  W E Mercer; M Amin; G J Sauve; E Appella; S J Ullrich; J W Romano
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

8.  The tumor suppressor p53 is bound to RNA by a stable covalent linkage.

Authors:  A Samad; R B Carroll
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

9.  Human p53 and CDC2Hs genes combine to inhibit the proliferation of Saccharomyces cerevisiae.

Authors:  J M Nigro; R Sikorski; S I Reed; B Vogelstein
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50.

Authors:  V Rotter; O N Witte; R Coffman; D Baltimore
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

View more
  26 in total

1.  Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

Authors:  L McKendrick; D Milne; D Meek
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Authors:  Y Wu; H Huang; Z Miner; M Kulesz-Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  CK2 interacting proteins: emerging paradigms for CK2 regulation?

Authors:  Mary Ellen K Olsten; Jane E Weber; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  Casein kinase 2 inhibits the renaturation of complementary DNA strands mediated by p53 protein.

Authors:  O Filhol; J Baudier; E M Chambaz; C Cochet
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

Review 5.  Regulation of p53 by protein kinase C during multi-stage carcinogenesis.

Authors:  L Magnelli; V Chiarugi
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF.

Authors:  E M Klenova; I V Chernukhin; A El-Kady; R E Lee; E M Pugacheva; D I Loukinov; G H Goodwin; D Delgado; G N Filippova; J León; H C Morse; P E Neiman; V V Lobanenkov
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 7.  Murine protein kinase CK2: gene and oncogene.

Authors:  X Xu; E Landesman-Bollag; P L Channavajhala; D C Seldin
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

8.  Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53.

Authors:  S J Ullrich; K Sakaguchi; S P Lees-Miller; M Fiscella; W E Mercer; C W Anderson; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Detection of antagonistic cellular regulatory functions by the gene-gene interference method in yeast.

Authors:  J Daniel
Journal:  Curr Genet       Date:  1996-01       Impact factor: 3.886

10.  Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389.

Authors:  Wendy Bruins; Edwin Zwart; Laura D Attardi; Tomoo Iwakuma; Esther M Hoogervorst; Rudolf B Beems; Barbara Miranda; Conny T M van Oostrom; Jolanda van den Berg; Gerard J van den Aardweg; Guillermina Lozano; Harry van Steeg; Tyler Jacks; Annemieke de Vries
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.